The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bourse Direct et Bourse Discount SA
PAR:BSD
|
FR |
|
Pierre et Vacances SA
PAR:VAC
|
FR |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
TGS ASA
OSE:TGS
|
NO |
|
A
|
Achieve Life Sciences Inc
F:SP4P
|
US |
|
O
|
Origin Energy Ltd
XMUN:ORL
|
AU |
|
Sandvik AB
STO:SAND
|
SE |
|
Empress Royalty Corp
F:53G
|
CA |
|
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
KR |
|
Archer Ltd
OSE:ARCH
|
BM |
|
Karat Packaging Inc
NASDAQ:KRT
|
US |
|
F
|
First Hydrogen Corp
OTC:FHYDF
|
CA |
|
A
|
Agilyx ASA
XMUN:5NQ
|
NO |
|
K
|
Keyrus SA
F:5UP
|
FR |
|
A
|
Asics Corp
XMUN:ASI1
|
JP |
|
A
|
Athens Medical Center SA
SWB:ACS
|
GR |
|
Progressive Planet Solutions Inc
F:ARB3
|
CA |
|
H
|
Honghua Group Ltd
XMUN:4HB
|
CN |
|
Jentech Precision Industrial Co Ltd
TWSE:3653
|
TW |
|
S
|
Subaru Corp
DUS:FUH
|
JP |
|
T
|
Toyota Motor Corp
BMV:TMN
|
JP |
Bourse Direct et Bourse Discount SA (BSD)’s 12-month stock price forecast through October 2027 has a consensus target of €7.14, implying 44% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
BSD is 7.14 EUR with a low forecast of 7.07 EUR and a high forecast of 7.35 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 10%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more